RE: JP Morgan Conference & Biotech Showcase12 Jan 2026 10:16
Teva, Royalty Pharma announce $500M deal to advance autoimmune drug
New partnership aimed at advancing Israeli pharma giant's anti-IL-15 drug for autoimmune diseases; CEO Richard Francis to detail growth strategy and pipeline progress at J.P. Morgan Healthcare Conference on Jan. 13